Healthcare Services

An Important Factor Driving the Chromatin immunoprecipitation (ChIP) Sequencing Market Is the Prostate Cancer Prevalence Boosting Growth In The Chromatin Immunoprecipitation (Chip) Sequencing Market

March 31, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Chromatin immunoprecipitation (ChIP) Sequencing Market During The Forecast Period 2026–2030?

The chromatin immunoprecipitation (chip) sequencing market has experienced swift expansion recently. Projections indicate its value will increase from $15.48 billion in 2025 to $17.42 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.5%. This historical growth is largely due to factors such as the broadening of fundamental genomics research, a rise in academic research funding, the widespread availability of next-generation sequencing platforms, escalating interest in chromatin biology, and the proliferation of molecular biology laboratories.

The chromatin immunoprecipitation (chip) sequencing market size is projected to experience swift expansion over the coming years, with expectations to reach $29.02 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.6%. This anticipated growth during the forecast period is primarily driven by increasing investments in epigenomics research, the rising adoption of AI-driven genomic analysis, the expansion of precision medicine initiatives, a growing demand for multi-omics integration, and the increasing use of cloud-based bioinformatics platforms. Additionally, major trends in the forecast period include the increasing use of genome-wide protein-DNA interaction mapping, the rising adoption of high-throughput sequencing platforms, a growing demand for epigenetics research tools, the expansion of integrated bioinformatics analysis pipelines, and an enhanced focus on regulatory genomics studies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13265&type=smp

What Drivers Are Expected To Influence The Chromatin immunoprecipitation (ChIP) Sequencing Market During The Forecast Period?

The rising incidence of prostate cancer is anticipated to fuel the expansion of the chromatin immunoprecipitation (ChIP) sequencing market in the coming period. Prostate cancer constitutes a malignancy originating in the prostate gland, a male reproductive organ comparable in size to a walnut, responsible for generating seminal fluid. Within the domain of prostate cancer investigation, ChIP-seq provides an extensive insight into the molecular mechanisms underlying the condition, yielding crucial data that enhances comprehension of the disease’s biology and facilitates the creation of more precise and potent treatment strategies. Illustratively, data from January 2023, sourced from the American Cancer Society, a US-based organization dedicated to combating cancer, indicated an estimated 288,300 new cases of prostate cancer and 34,700 deaths attributed to the disease in the US during 2023. Consequently, the growing occurrence of prostate cancer is significantly boosting the chromatin immunoprecipitation (ChIP) sequencing market’s expansion.

What Market Segments Are Evaluated Within The Chromatin immunoprecipitation (ChIP) Sequencing Market?

The chromatin immunoprecipitation (chip) sequencing market covered in this report is segmented –

1) By Type: DNase-Sequencing, FAIRE-Sequencing

2) By Technology: Targeted Sequencing And Re-Sequencing, Whole Genome Sequencing And Whole Exome Sequencing

3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis

4) By Application: Consumables And Reagents, Service, Other Applications

5) By End-User: Academic Research Institutes, Clinical Research Institutes, Hospitals And Clinics, Pharmaceuticals And Biotechnology Companies, Other End Users

Subsegments:

1) By DNase-Sequencing: DNase I Hypersensitivity Mapping, DNase-Seq For Open Chromatin Regions

2) By FAIRE-Sequencing: Formaldehyde-Assisted Isolation Of Regulatory Elements (FAIRE), FAIRE-Seq For Active Regulatory Regions

Which Trends Are Influencing The Chromatin immunoprecipitation (ChIP) Sequencing Market?

Major companies in the chromatin immunoprecipitation (ChIP) sequencing market are focusing on innovative technologies, such as hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing), to enhance the efficiency and accuracy of epigenomic research, which is ultimately driving advancements in drug discovery and personalized medicine. hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing) is an advanced technology designed to improve the study of epigenetic modifications across the genome. For instance, in June 2024, Epigenica, a Sweden-based life sciences technology company, introduced its EpiFinder Platform, which features patented hmqChIP-seq technology that allows for high-throughput, multiplex quantitative analysis in epigenomic research. This innovative platform enables researchers to generate 192 genome-wide profiles simultaneously from up to 24 samples, thereby streamlining large-scale experiments with unprecedented speed and cost-efficiency.

Who Are The Top Market Participants Influencing The Chromatin immunoprecipitation (ChIP) Sequencing Market?

Major companies operating in the chromatin immunoprecipitation (chip) sequencing market are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc. , Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc. , PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Porvair Sciences Ltd. , Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.

Read the full chromatin immunoprecipitation (chip) sequencing market report here:

https://www.thebusinessresearchcompany.com/report/chromatin-immunoprecipitation-chip-sequencing-global-market-report

Which Region Is Forecast To Lead The Chromatin immunoprecipitation (ChIP) Sequencing Market In Terms Of Market Size?

North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Chromatin immunoprecipitation (ChIP) Sequencing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13265&type=smp

Browse Through More Reports Similar to the Global Chromatin immunoprecipitation (ChIP) Sequencing Market 2026, By The Business Research Company

Intravascular Ultrasound Global Market Report

https://www.thebusinessresearchcompany.com/report/intravascular-ultrasound-global-market-report

Vascular Imaging Global Market Report

https://www.thebusinessresearchcompany.com/report/vascular-imaging-global-market-report

Ocular Hypertension Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/ocular-hypertension-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795